
Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65562 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Gefitinib
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H24ClFN4O3Color and Shape:White PowderMolecular weight:446.1521Mirabegron
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C21H24N4O2SColor and Shape:White Off-White Brownish Yellow Crystalline PowderMolecular weight:396.162Gefitinib Related Compound B (N-(4-Chloro-3-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H24ClFN4O3Color and Shape:Light Yellow PowderMolecular weight:446.1521Methyl Acetate
CAS:Esters of acetic acid not elsewhere specified or includFormula:C3H6O2Color and Shape:Colorless Clear LiquidMolecular weight:74.08 g/molArgatroban Related Compound B (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride)
CAS:<p>Compounds containing an unfused pyridine ring in the structure, nesoi</p>Formula:C15H28N6O5·2HClColor and Shape:Off-White PowderMolecular weight:444.16547Deschlorosorafenib (N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide; N-Methyl-4-{4-[3-(3-trifluoromethylphenyl)ureido]phenoxy}picolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H17F3N4O3Color and Shape:White Off-White SolidMolecular weight:430.12527Chlorothiophene Aldehyde (5-chlorothiophene-2-carbaldehyde)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H3ClOSColor and Shape:Brown LiquidMolecular weight:145.95931Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
CAS:Sulfonamides, nesoiFormula:C23H31N7O7SColor and Shape:White PowderMolecular weight:549.200575-Hydroxymethylfurfural (5-(Hydroxymethyl)-2-furaldehyde)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C6H6O3Color and Shape:Yellow SolidMolecular weight:126.03169Alcohol Determination - Alcohol
CAS:Other spirituous beverages, nesoiFormula:C2H6OColor and Shape:Colorless Translucent LiquidMolecular weight:46.04186Clozapine
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C18H19ClN4Color and Shape:Yellow PowderMolecular weight:326.12982Omeprazole Related Compound E (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H19N3O4SColor and Shape:Off-White PowderMolecular weight:361.10963Nadolol Related Compound G (1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C17H27NO2Color and Shape:Off-White PowderMolecular weight:277.20418Sildenafil Related Compound A (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C23H32N6O4SColor and Shape:White PowderMolecular weight:488.22057Ondansetron Hydrochloride
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C18H19N3O·HCl·2H2OColor and Shape:White Off-White PowderMolecular weight:293.15281Paroxetine System Suitability Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White Off-White PowderNadolol Related Compound C
<p>Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or included</p>Formula:C23H28O7Color and Shape:Off-White SolidMolecular weight:416.1835Polyvinyl Alcohol
CAS:Polyvinyl alcohols, whether or not containing unhydrolyzed acetate groupsFormula:H(C2H4O)m(C4H6O2)nHColor and Shape:PowderMolecular weight:46.0684Ofloxacin Related Compound A (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C17H18FN3O4Color and Shape:Light Yellow PowderMolecular weight:347.12813Dichloroaniline (3,4-Dichloroaniline)
CAS:Aniline derivatives and their saltsFormula:C6H5Cl2NColor and Shape:Light Brown Off-White CrystalsMolecular weight:160.9799

